Dr. Jon Bloom is a board-certified physician and entrepreneur with over 15 years of experience in technology development, patient monitoring, biomedical research, and health care delivery.  He is the chief executive officer of Podimetrics, a care management company with the leading solution to help prevent diabetic foot ulcers, one of the most debilitating and costly complications of diabetes. Dr. Bloom co-founded Podimetrics in 2011 while a student at the MIT Sloan School of Management. Podimetrics combines an FDA-cleared SmartMat™ with wraparound care management to spot signs of ulcers, on average, five weeks before they usually would present clinically. By combining cutting-edge technology with best-in-class care management, Podimetrics earns high engagement rates from patients and achieves unparalleled outcomes saving limbs, lives, and money. Dr. Bloom served as a Clinical Assistant Professor and staff anesthesiologist at the University of Pittsburgh Medical Center. He also served as the Director of Global Medical Affairs for Covidien’s Respiratory and Monitoring Solutions division in Boulder, Colorado. Dr. Bloom is a diplomate of the American Board of Anesthesiology, completing residency at the Massachusetts General Hospital. He has co-authored more than 20 peer-reviewed publications with a primary focus on health care economics and perioperative complications.

As a Partner on the Healthcare Services team at Deerfield, Leslie works with a variety of healthcare services and healthcare information technology companies that are both current and potential investment partners. Before joining Deerfield in 2005, Leslie was co-manager of an ING branded healthcare hedge fund she launched in 2000. Prior to that she spent eleven years in the investment banking, high yield research and equity research departments at Furman Selz and ING, where she focused exclusively on companies in the healthcare arena. Leslie currently sits on five corporate boards and is a member of the Polsky Council affiliated with the University of Chicago.

Emily received her PhD from the Harvard-MIT division of Health Sciences & Technology. Her graduate research centered around neuroimaging of the aging brain, with an emphasis on understanding novel biomarkers of Alzheimer’s disease. During her studies, she participated in the 2016 MIT Hacking Medicine Grand Hack, from which her company Hey,Charlie was born. Hey,Charlie is a digital platform that focuses on the social connectivity of individuals in recovery for substance use disorder (SUD) that offers novel behavioral modification techniques for SUD, and has been piloted at several locations across the US. In parallel, Emily has pursued a varied career in the digital health industry beyond her graduate studies. She has worked as a staff scientist at a neuroimaging start-up in Cambridge, as a scientist at IBM Watson Health, and is currently leads the data science division of a digital health company in Boston called Wellframe. She is a strong advocate for women in STEM and has demonstrated this through her instructor role for the Girls Who Code national organization and as the executive co-chair of Graduate Women at MIT. In her free time, Emily is an avid reader and has a lifelong goal of visiting all 61 of America’s National Parks. So far she has seen 20.

Chris Molaro is the CEO and co-founder of NeuroFlow, a digital health technology and analytics company promoting behavioral health access and engagement in all care settings. Chris is a former U.S. Army Captain from the US Military Academy at West Point and earned his MBA at The Wharton School at the University of Pennsylvania where he also spent time as digital health consultant at Mckinsey. Chris was also the founder of the literacy non-profit Things We Read.